Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial

Author:

Postlewait Lauren M.1,Ethun Cecilia G.1,Kooby David A.1,Sarmiento Juan M.2,Chen Zhengjia3,Staley Charles A.1,Brutcher Edith4,Adsay Volkan5,El-Rayes Bassel4,Maithel Shishir K.1

Affiliation:

1. Division of Surgical Oncology, Department of Surgery; Winship Cancer Institute, Emory University; Atlanta Georgia

2. Division of General Surgery, Department of Surgery; Emory University; Atlanta Georgia

3. Department of Biostatistics and Bioinformatics, Rollins School of Public Health; Emory University; Atlanta Georgia

4. Department of Medical Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

5. Department of Pathology, Winship Cancer Institute; Emory University; Atlanta Georgia

Funder

Biostatistics Shared Resource and Clinical Trials Office of Winship Cancer Institute of Emory University

NIH/NCI

Katz Foundation

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3